Browsing by Author "Inanc, Mevlude"
Now showing items 1-5 of 5
-
Clinicopathological Characteristics and Prognosis of Patients According To Recurrence Time After Radical Nephrectomy for Localized Renal Cell Carcinoma: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO)
Bozkurt, Oktay; Inanc, Mevlude; Hacibekiroglu, Ilhan; Esbah, Onur; Seker, Metin; Ulas, Arife; Aydin, Kubra; Uysal, Mukremin; Kucukoner, Mehmet; Uncu, Dogan; Ciltas, Aydin; Unal, Olcun Umit; Durnali, Ayse; Demirci, Umut; Berk, Veli; Tonyali, Onder; Oksuzoglu, Berna; Karaca, Halit; Ozkan, Metin (INT INST ANTICANCER RESEARCH, 2014)Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years or more than 5 years after nephrectomy and determined predictors of survival and response treatment after recurrence. ... -
Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer
Ozaslan, Ersin; Topaloglu, Ulas Serkan; Inanc, Mevlude; Erdem, Umut Gokmen; Demir, Hacer; Arpaci, Erkan; Seker, Mehmet Metin; Karaaga, Mustafa; Kiziltepe, Melih; Eker, Baki; Ozkan, Metin (IMPRIMATUR PUBLICATIONS, 2017)Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients. Methods: IPatients were administered cetuximab ... -
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology
Arpaci, Erkan; Yetisyigit, Tarkan; Seker, Metin; Uncu, Dogan; Uyeturk, Ummugul; Oksuzoglu, Berna; Demirci, Umut; Coskun, Ugur; Kucukoner, Mehmet; Isikdogan, Abdurrahman; Inanc, Mevlude; Alkis, Necati; Ozkan, Metin (HUMANA PRESS INC, 2013)The aim of this study was to evaluate prognostic factors, survival rate and the efficacy of the treatment modalities used in patients with Ewing sarcoma family of tumors (ESFT). Data of patients with ESFTs followed up at ... -
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
Durnali, Ayse; Alkis, Necati; Cangur, Sengul; Yukruk, Fisun Ardic; Inal, Ali; Tokluoglu, Saadet; Seker, Mehmet Metin; Bal, Oznur; Akman, Tulay; Inanc, Mevlude; Isikdogan, Abdurrahman; Demirci, Ayse; Helvaci, Kaan; Oksuzoglu, Berna (HUMANA PRESS INC, 2013)The aim of this retrospective, multicenter study was to evaluate clinicopathological characteristics, prognostic factors and treatment outcomes of teenage and adult patients with high-grade osteosarcoma. A total of 240 ... -
XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
Duran, Ayse Ocak; Karaca, Halit; Besiroglu, Mehmet; Bayoglu, Ibrahim Vedat; Menekse, Serkan; Yapici, Heves Surmeli; Yazilitas, Dogan; Bahceci, Aykut; Uysal, Mukremin; Sevinc, Alper; Hacibekiroglu, Ilhan; Aksoy, Asude; Tanriverdi, Ozgur; Arpaci, Erkan; Inanc, Mevlude; Dane, Faysal; Ozkan, Metin (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this study was to compare ...